Total Payments
$641.88
2024 Payments
$16.59
Companies
9
Transactions
30
Medicare Patients
696
Medicare Billing
$57,117
Payment Breakdown by Category
Food & Beverage$641.88 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $641.88 | 30 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $180.21 | 9 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $153.88 | 6 | $0 (2022) |
| PFIZER INC. | $86.53 | 4 | $0 (2023) |
| ABBVIE INC. | $82.23 | 4 | $0 (2024) |
| Merck Sharp & Dohme LLC | $53.85 | 3 | $0 (2022) |
| Aurinia Pharma U.S., Inc. | $23.36 | 1 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $23.23 | 1 | $0 (2022) |
| Shionogi Inc | $22.69 | 1 | $0 (2021) |
| Novo Nordisk Inc | $15.90 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.59 | 1 | ABBVIE INC. ($16.59) |
| 2023 | $79.25 | 4 | E.R. Squibb & Sons, L.L.C. ($35.53) |
| 2022 | $224.75 | 10 | E.R. Squibb & Sons, L.L.C. ($79.55) |
| 2021 | $134.49 | 6 | Janssen Pharmaceuticals, Inc ($47.76) |
| 2020 | $21.72 | 1 | E.R. Squibb & Sons, L.L.C. ($21.72) |
| 2019 | $149.18 | 7 | Janssen Pharmaceuticals, Inc ($48.01) |
| 2017 | $15.90 | 1 | Novo Nordisk Inc ($15.90) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/05/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/16/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.92 | General |
| Category: Cardiovascular | ||||||
| 10/02/2023 | AbbVie Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/01/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.61 | General |
| Category: Cardiovascular | ||||||
| 03/02/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/14/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.76 | General |
| Category: Cardiovascular | ||||||
| 11/02/2022 | PFIZER INC. | ELIQUIS (Drug), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/15/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/08/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.17 | General |
| Category: Cardiovascular | ||||||
| 04/04/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/01/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.80 | General |
| Category: Cardiovascular | ||||||
| 03/18/2022 | Merck Sharp & Dohme LLC | PNEUMOVAX 23 (Biological), VAXNEUVANCE | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: VACCINE | ||||||
| 03/16/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/25/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $29.11 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/18/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.82 | General |
| Category: Cardiovascular | ||||||
| 12/14/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/07/2021 | Merck Sharp & Dohme Corporation | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/04/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/09/2021 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 08/11/2021 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: Infections and Infectious Diseases | ||||||
| 06/23/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.19 | General |
| Category: Cardiovascular | ||||||
| 01/07/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.72 | General |
| Category: Cardiovascular | ||||||
| 11/06/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Immunology | ||||||
| 11/06/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $22.50 | General |
| 10/21/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $14.92 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 191 | 308 | $31,180 | $15,754 |
| 2022 | 10 | 193 | 311 | $29,460 | $15,497 |
| 2021 | 8 | 170 | 290 | $27,970 | $13,992 |
| 2020 | 6 | 142 | 272 | $28,710 | $11,875 |
Total Patients
696
Total Services
1,181
Medicare Billing
$57,117
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 136 | $20,400 | $9,219 | 45.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 18 | 18 | $3,240 | $2,670 | 82.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 12 | 18 | $1,800 | $986.62 | 54.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 24 | $2,220 | $722.29 | 32.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 23 | 23 | $1,070 | $494.96 | 46.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 13 | 14 | $420.00 | $411.60 | 98.0% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 12 | 12 | $480.00 | $398.16 | 83.0% |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | Office | 2023 | 16 | 16 | $480.00 | $310.93 | 64.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 14 | 15 | $750.00 | $271.98 | 36.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 23 | 32 | $320.00 | $268.80 | 84.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 37 | 120 | $18,000 | $8,105 | 45.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 14 | 14 | $2,520 | $2,183 | 86.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 21 | 32 | $3,150 | $1,946 | 61.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 17 | 26 | $2,350 | $1,372 | 58.4% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 15 | 15 | $600.00 | $472.76 | 78.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 21 | 21 | $770.00 | $467.55 | 60.7% |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | Office | 2022 | 17 | 19 | $570.00 | $393.94 | 69.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 13 | 13 | $390.00 | $382.80 | 98.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 24 | 36 | $360.00 | $106.74 | 29.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 14 | 15 | $750.00 | $67.75 | 9.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 141 | $21,150 | $9,871 | 46.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 15 | 15 | $2,600 | $2,237 | 86.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 21 | 21 | $630.00 | $473.76 | 75.2% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 28 | 36 | $1,800 | $458.58 | 25.5% |
| 90674 | Vaccine for influenza derived from cell cultures for administration into muscle, 0.5 ml dosage, quadrivalent, , preservative and antibiotic free | Office | 2021 | 12 | 12 | $500.00 | $359.28 | 71.9% |
About Dr. Mohammed Basith, M.D
Dr. Mohammed Basith, M.D is a Internal Medicine healthcare provider based in Ozone Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/06/2010. The National Provider Identifier (NPI) number assigned to this provider is 1144548843.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammed Basith, M.D has received a total of $641.88 in payments from pharmaceutical and medical device companies, with $16.59 received in 2024. These payments were reported across 30 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($641.88).
As a Medicare-enrolled provider, Basith has provided services to 696 Medicare beneficiaries, totaling 1,181 services with total Medicare billing of $57,117. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Ozone Park, NY
- Active Since 05/06/2010
- Last Updated 07/06/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1144548843
Products in Payments
- ELIQUIS (Drug) $232.28
- XARELTO (Drug) $153.88
- LUPKYNIS (Drug) $23.36
- ENTRESTO (Drug) $23.23
- Fetroja (Drug) $22.69
- Humira (Biological) $22.68
- TEFLARO (Drug) $20.46
- VERQUVO (Drug) $19.49
- PNEUMOVAX 23 (Biological) $19.44
- DALVANCE (Drug) $16.59
- CAMZYOS (Drug) $15.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Ozone Park
Dr. Michael Avaricio, Md, MD
Internal Medicine — Payments: $43,403
Internal Medicine $43,403
Dr. Woosup Kim, Md, MD
Internal Medicine — Payments: $2,370
Internal Medicine $2,370
Dr. Lola Iskhakova, Md, MD
Internal Medicine — Payments: $2,336
Internal Medicine $2,336
Mohammed Siddique, Md, MD
Internal Medicine — Payments: $1,289
Internal Medicine $1,289
Dr. Sharad Soni, M.d, M.D
Internal Medicine — Payments: $610.13
Internal Medicine $610.13
Luis Almonte, Md, MD
Internal Medicine — Payments: $599.36
Internal Medicine $599.36